106 related articles for article (PubMed ID: 38850034)
1. Induction of cGMP-mediated migraine attacks is independent of CGRP receptor activation.
Raffaelli B; Do TP; Ashina H; Snellman J; Maio-Twofoot T; Ashina M
Cephalalgia; 2024 Jun; 44(6):3331024241259489. PubMed ID: 38850034
[TBL] [Abstract][Full Text] [Related]
2. Activation of ATP-sensitive potassium channels triggers migraine attacks independent of calcitonin gene-related peptide receptors: a randomized placebo-controlled trial.
Raffaelli B; Do TP; Chaudhry BA; Amin FM; Ashina H; Snellman J; Maio-Twofoot T; Ashina M
Cephalalgia; 2024 Jan; 44(1):3331024231222916. PubMed ID: 38181724
[TBL] [Abstract][Full Text] [Related]
3. Investigation of distinct molecular pathways in migraine induction using calcitonin gene-related peptide and sildenafil.
Younis S; Christensen CE; Toft NM; Søborg T; Amin FM; Hougaard A; Ashina M
Cephalalgia; 2019 Dec; 39(14):1776-1788. PubMed ID: 31684759
[TBL] [Abstract][Full Text] [Related]
4. Migraine induction with calcitonin gene-related peptide in patients from erenumab trials.
Christensen CE; Younis S; Deen M; Khan S; Ghanizada H; Ashina M
J Headache Pain; 2018 Nov; 19(1):105. PubMed ID: 30409109
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of cAMP, cGMP and CGRP in sildenafil-induced headache.
Kruuse C; Frandsen E; Schifter S; Thomsen LL; Birk S; Olesen J
Cephalalgia; 2004 Jul; 24(7):547-53. PubMed ID: 15196297
[TBL] [Abstract][Full Text] [Related]
6. The headache and aura-inducing effects of sildenafil in patients with migraine with aura.
Butt JH; S Eddelien H; Kruuse C
Cephalalgia; 2022 Sep; 42(10):984-992. PubMed ID: 35332812
[TBL] [Abstract][Full Text] [Related]
7. Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial.
Vollesen ALH; Snoer A; Beske RP; Guo S; Hoffmann J; Jensen RH; Ashina M
JAMA Neurol; 2018 Oct; 75(10):1187-1197. PubMed ID: 29987329
[TBL] [Abstract][Full Text] [Related]
8. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter.
Kruuse C; Thomsen LL; Birk S; Olesen J
Brain; 2003 Jan; 126(Pt 1):241-7. PubMed ID: 12477710
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab.
Al-Khazali HM; Ashina H; Christensen RH; Wiggers A; Rose K; Iljazi A; Amin FM; Ashina M; Snellman J; Maio-Twofoot T; Schytz HW
Cephalalgia; 2024 Jun; 44(6):3331024241258734. PubMed ID: 38859744
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
Reuter U; Goadsby PJ; Lanteri-Minet M; Wen S; Hours-Zesiger P; Ferrari MD; Klatt J
Lancet; 2018 Nov; 392(10161):2280-2287. PubMed ID: 30360965
[TBL] [Abstract][Full Text] [Related]
11. Second messenger signalling bypasses CGRP receptor blockade to provoke migraine attacks in humans.
Do TP; Deligianni C; Amirguliyev S; Snellman J; Lopez CL; Al-Karagholi MA; Guo S; Ashina M
Brain; 2023 Dec; 146(12):5224-5234. PubMed ID: 37540009
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Tepper S; Ashina M; Reuter U; Brandes JL; Doležil D; Silberstein S; Winner P; Leonardi D; Mikol D; Lenz R
Lancet Neurol; 2017 Jun; 16(6):425-434. PubMed ID: 28460892
[TBL] [Abstract][Full Text] [Related]
13. Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.
Falkenberg K; Rønde Bjerg H; Yamani N; Olesen J
Headache; 2020 Apr; 60(4):665-676. PubMed ID: 31944310
[TBL] [Abstract][Full Text] [Related]
14. Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.
Mullin K; Kudrow D; Croop R; Lovegren M; Conway CM; Coric V; Lipton RB
Neurology; 2020 May; 94(20):e2121-e2125. PubMed ID: 31932515
[TBL] [Abstract][Full Text] [Related]
15. Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers.
de Hoon J; Van Hecken A; Vandermeulen C; Herbots M; Kubo Y; Lee E; Eisele O; Vargas G; Gabriel K
Cephalalgia; 2019 Jan; 39(1):100-110. PubMed ID: 29783863
[TBL] [Abstract][Full Text] [Related]
16. A new era for migraine: The role of calcitonin gene-related peptide in the trigeminovascular system.
Chen ST; Wu JW
Prog Brain Res; 2020; 255():123-142. PubMed ID: 33008504
[TBL] [Abstract][Full Text] [Related]
17. Effects of sildenafil and calcitonin gene-related peptide on brainstem glutamate levels: a pharmacological proton magnetic resonance spectroscopy study at 3.0 T.
Younis S; Hougaard A; Christensen CE; Vestergaard MB; Petersen ET; Paulson OB; Larsson HBW; Ashina M
J Headache Pain; 2018 Jun; 19(1):44. PubMed ID: 29916084
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers.
Christensen CE; Amin FM; Younis S; Lindberg U; de Koning P; Petersen ET; Paulson OB; Larsson HBW; Ashina M
Cephalalgia; 2019 Feb; 39(2):264-273. PubMed ID: 29976087
[TBL] [Abstract][Full Text] [Related]
19. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
20. Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
Dodick DW; Goadsby PJ; Schwedt TJ; Lipton RB; Liu C; Lu K; Yu SY; Severt L; Finnegan M; Trugman JM
Lancet; 2023 Dec; 402(10419):2307-2316. PubMed ID: 37979595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
